Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
RAFA Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 15, 2026
Report Source: 2025 3rd Quarter Report
Rafarma Pharmaceuticals Inc. Stock Analysis RAFA
Rafarma Pharmaceuticals, Inc. engages in the manufacture and marketing of pharmaceutical goods. The company is headquartered in Draper, Utah. The company went IPO on 2001-07-11. The firm is owned with a portfolio of companies that manufacture and distribute generic drugs, equipment and drugs for nuclear medicine, research on new drugs, as well as a complex of vivarium laboratories that develop high technology drugs in the biotechnology sector. The firm's subsidiaries include LLC MSCH Slavich, LLC Trading House Slavich and Slavich Noya Technologies LLC.
Read More Rafarma Pharmaceuticals Inc (RAFA) Chart
Key Statistics of Rafarma Pharmaceuticals Inc (RAFA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
1570.00P/E Ratio (TTM)
-52 Week Range
Market Cap
5.59MAvg. Volume
7597.40Dividend Yield
-Financial Metrics & Statements of Rafarma Pharmaceuticals Inc (RAFA)
FAQ's for Rafarma Pharmaceuticals Inc (RAFA)
- According to Musaffa’s Shariah screening methodology, Rafarma Pharmaceuticals Inc (RAFA) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rafarma Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Rafarma Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Rafarma Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Rafarma Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Rafarma Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.